Global Medical Transdermal Patch Market Research Report 2023

TABLE OF CONTENTS

1 Medical Transdermal Patch Market Overview

• 1.1 Product Overview and Scope of Medical Transdermal Patch
• 1.2 Medical Transdermal Patch Segment by Type
  • 1.2.1 Global Medical Transdermal Patch Market Value Comparison by Type (2023-2029)
  • 1.2.2 Methyl Salicylate-based Patch
  • 1.2.3 Diclofenac Patch
  • 1.2.4 Nicotine Transdermal Patch
  • 1.2.5 Others
• 1.3 Medical Transdermal Patch Segment by Application
  • 1.3.1 Global Medical Transdermal Patch Market Value by Application: (2023-2029)
  • 1.3.2 Rx Channel
  • 1.3.3 OTC Channel
• 1.4 Global Medical Transdermal Patch Market Size Estimates and Forecasts
  • 1.4.1 Global Medical Transdermal Patch Revenue 2018-2029
  • 1.4.2 Global Medical Transdermal Patch Sales 2018-2029
  • 1.4.3 Global Medical Transdermal Patch Market Average Price (2018-2029)
• 1.5 Assumptions and Limitations

2 Medical Transdermal Patch Market Competition by Manufacturers

• 2.1 Global Medical Transdermal Patch Sales Market Share by Manufacturers (2018-2023)
• 2.2 Global Medical Transdermal Patch Revenue Market Share by Manufacturers (2018-2023)
• 2.3 Global Medical Transdermal Patch Average Price by Manufacturers (2018-2023)
• 2.4 Global Medical Transdermal Patch Industry Ranking 2021 VS 2022 VS 2023
• 2.5 Global Key Manufacturers of Medical Transdermal Patch, Manufacturing Sites & Headquarters
• 2.6 Global Key Manufacturers of Medical Transdermal Patch, Product Type & Application
• 2.7 Medical Transdermal Patch Market Competitive Situation and Trends
  • 2.7.1 Medical Transdermal Patch Market Concentration Rate
  • 2.7.2 The Global Top 5 and Top 10 Largest Medical Transdermal Patch Players Market Share by Revenue
  • 2.7.3 Global Medical Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Medical Transdermal Patch Retrospective Market Scenario by Region

• 3.1 Global Medical Transdermal Patch Market Size by Region: 2018 Versus 2022 Versus 2029
• 3.2 Global Medical Transdermal Patch Global Medical Transdermal Patch Sales by Region: 2018-2029
  • 3.2.1 Global Medical Transdermal Patch Sales by Region: 2018-2023
  • 3.2.2 Global Medical Transdermal Patch Sales by Region: 2024-2029
• 3.3 Global Medical Transdermal Patch Global Medical Transdermal Patch Revenue by Region: 2018-2029
  • 3.3.1 Global Medical Transdermal Patch Revenue by Region: 2018-2023
  • 3.3.2 Global Medical Transdermal Patch Revenue by Region: 2024-2029
• 3.4 North America Medical Transdermal Patch Market Facts & Figures by Country
  • 3.4.1 North America Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
  • 3.4.2 North America Medical Transdermal Patch Sales by Country (2018-2029)
  • 3.4.3 North America Medical Transdermal Patch Revenue by Country (2018-2029)
  • 3.4.4 United States
  • 3.4.5 Canada
• 3.5 Europe Medical Transdermal Patch Market Facts & Figures by Country
  • 3.5.1 Europe Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
  • 3.5.2 Europe Medical Transdermal Patch Sales by Country (2018-2029)
  • 3.5.3 Europe Medical Transdermal Patch Revenue by Country (2018-2029)
  • 3.5.4 Germany
  • 3.5.5 France
  • 3.5.6 U.K.
  • 3.5.7 Italy
  • 3.5.8 Russia
• 3.6 Asia Pacific Medical Transdermal Patch Market Facts & Figures by Country
  • 3.6.1 Asia Pacific Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
  • 3.6.2 Asia Pacific Medical Transdermal Patch Sales by Country (2018-2029)
  • 3.6.3 Asia Pacific Medical Transdermal Patch Revenue by Country (2018-2029)
  • 3.6.4 China
  • 3.6.5 Japan
  • 3.6.6 South Korea
  • 3.6.7 India
  • 3.6.8 Australia
  • 3.6.9 China Taiwan
  • 3.6.10 Indonesia
  • 3.6.11 Thailand
  • 3.6.12 Malaysia
• 3.7 Latin America Medical Transdermal Patch Market Facts & Figures by Country
  • 3.7.1 Latin America Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
  • 3.7.2 Latin America Medical Transdermal Patch Sales by Country (2018-2029)
  • 3.7.3 Latin America Medical Transdermal Patch Revenue by Country (2018-2029)
  • 3.7.4 Mexico
  • 3.7.5 Brazil
  • 3.7.6 Argentina
• 3.8 Middle East and Africa Medical Transdermal Patch Market Facts & Figures by Country
  • 3.8.1 Middle East and Africa Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
  • 3.8.2 Middle East and Africa Medical Transdermal Patch Sales by Country (2018-2029)
  • 3.8.3 Middle East and Africa Medical Transdermal Patch Revenue by Country (2018-2029)
  • 3.8.4 Turkey
  • 3.8.5 Saudi Arabia
  • 3.8.6 UAE

4 Segment by Type

• 4.1 Global Medical Transdermal Patch Sales by Type (2018-2029)
  • 4.1.1 Global Medical Transdermal Patch Sales by Type (2018-2023)
  • 4.1.2 Global Medical Transdermal Patch Sales by Type (2024-2029)
  • 4.1.3 Global Medical Transdermal Patch Sales Market Share by Type (2018-2029)
• 4.2 Global Medical Transdermal Patch Revenue by Type (2018-2029)
  • 4.2.1 Global Medical Transdermal Patch Revenue by Type (2018-2023)
  • 4.2.2 Global Medical Transdermal Patch Revenue by Type (2024-2029)
  • 4.2.3 Global Medical Transdermal Patch Revenue Market Share by Type (2018-2029)
• 4.3 Global Medical Transdermal Patch Price by Type (2018-2029)

5 Segment by Application

• 5.1 Global Medical Transdermal Patch Sales by Application (2018-2029)
  • 5.1.1 Global Medical Transdermal Patch Sales by Application (2018-2023)
  • 5.1.2 Global Medical Transdermal Patch Sales by Application (2024-2029)
  • 5.1.3 Global Medical Transdermal Patch Sales Market Share by Application (2018-2029)
• 5.2 Global Medical Transdermal Patch Revenue by Application (2018-2029)
  • 5.2.1 Global Medical Transdermal Patch Revenue by Application (2018-2023)
  • 5.2.2 Global Medical Transdermal Patch Revenue by Application (2024-2029)
  • 5.2.3 Global Medical Transdermal Patch Revenue Market Share by Application (2018-2029)
• 5.3 Global Medical Transdermal Patch Price by Application (2018-2029)

6 Key Companies Profiled

• 6.1 Hisamitsu Pharmaceutical
  • 6.1.1 Hisamitsu Pharmaceutical Corporation Information
  • 6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
  • 6.1.3 Hisamitsu Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.1.4 Hisamitsu Pharmaceutical Medical Transdermal Patch Product Portfolio
  • 6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
• 6.2 Johnson & Johnson
  • 6.2.1 Johnson & Johnson Corporation Information
  • 6.2.2 Johnson & Johnson Description and Business Overview
  • 6.2.3 Johnson & Johnson Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.2.4 Johnson & Johnson Medical Transdermal Patch Product Portfolio
  • 6.2.5 Johnson & Johnson Recent Developments/Updates
• 6.3 Novartis
  • 6.3.1 Novartis Corporation Information
  • 6.3.2 Novartis Description and Business Overview
  • 6.3.3 Novartis Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.3.4 Novartis Medical Transdermal Patch Product Portfolio
  • 6.3.5 Novartis Recent Developments/Updates
• 6.4 UCB Pharma
  • 6.4.1 UCB Pharma Corporation Information
  • 6.4.2 UCB Pharma Description and Business Overview
  • 6.4.3 UCB Pharma Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.4.4 UCB Pharma Medical Transdermal Patch Product Portfolio
  • 6.4.5 UCB Pharma Recent Developments/Updates
• 6.5 Mylan
  • 6.5.1 Mylan Corporation Information
  • 6.5.2 Mylan Description and Business Overview
  • 6.5.3 Mylan Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.5.4 Mylan Medical Transdermal Patch Product Portfolio
  • 6.5.5 Mylan Recent Developments/Updates
• 6.6 Teva Pharmaceutical
  • 6.6.1 Teva Pharmaceutical Corporation Information
  • 6.6.2 Teva Pharmaceutical Description and Business Overview
  • 6.6.3 Teva Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.6.4 Teva Pharmaceutical Medical Transdermal Patch Product Portfolio
  • 6.6.5 Teva Pharmaceutical Recent Developments/Updates
• 6.7 Nitto Denko
  • 6.6.1 Nitto Denko Corporation Information
  • 6.6.2 Nitto Denko Description and Business Overview
  • 6.6.3 Nitto Denko Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.4.4 Nitto Denko Medical Transdermal Patch Product Portfolio
  • 6.7.5 Nitto Denko Recent Developments/Updates
• 6.8 Grunenthal
  • 6.8.1 Grunenthal Corporation Information
  • 6.8.2 Grunenthal Description and Business Overview
  • 6.8.3 Grunenthal Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.8.4 Grunenthal Medical Transdermal Patch Product Portfolio
  • 6.8.5 Grunenthal Recent Developments/Updates
• 6.9 IBSA Group
  • 6.9.1 IBSA Group Corporation Information
  • 6.9.2 IBSA Group Description and Business Overview
  • 6.9.3 IBSA Group Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.9.4 IBSA Group Medical Transdermal Patch Product Portfolio
  • 6.9.5 IBSA Group Recent Developments/Updates
• 6.10 GSK
  • 6.10.1 GSK Corporation Information
  • 6.10.2 GSK Description and Business Overview
  • 6.10.3 GSK Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.10.4 GSK Medical Transdermal Patch Product Portfolio
  • 6.10.5 GSK Recent Developments/Updates
• 6.11 Luye Pharma Group
  • 6.11.1 Luye Pharma Group Corporation Information
  • 6.11.2 Luye Pharma Group Medical Transdermal Patch Description and Business Overview
  • 6.11.3 Luye Pharma Group Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.11.4 Luye Pharma Group Medical Transdermal Patch Product Portfolio
  • 6.11.5 Luye Pharma Group Recent Developments/Updates
• 6.12 Pfizer
  • 6.12.1 Pfizer Corporation Information
  • 6.12.2 Pfizer Medical Transdermal Patch Description and Business Overview
  • 6.12.3 Pfizer Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.12.4 Pfizer Medical Transdermal Patch Product Portfolio
  • 6.12.5 Pfizer Recent Developments/Updates
• 6.13 Chattem
  • 6.13.1 Chattem Corporation Information
  • 6.13.2 Chattem Medical Transdermal Patch Description and Business Overview
  • 6.13.3 Chattem Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.13.4 Chattem Medical Transdermal Patch Product Portfolio
  • 6.13.5 Chattem Recent Developments/Updates
• 6.14 Bayer
  • 6.14.1 Bayer Corporation Information
  • 6.14.2 Bayer Medical Transdermal Patch Description and Business Overview
  • 6.14.3 Bayer Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.14.4 Bayer Medical Transdermal Patch Product Portfolio
  • 6.14.5 Bayer Recent Developments/Updates
• 6.15 Mundipharma
  • 6.15.1 Mundipharma Corporation Information
  • 6.15.2 Mundipharma Medical Transdermal Patch Description and Business Overview
  • 6.15.3 Mundipharma Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.15.4 Mundipharma Medical Transdermal Patch Product Portfolio
  • 6.15.5 Mundipharma Recent Developments/Updates
• 6.16 Endo International
  • 6.16.1 Endo International Corporation Information
  • 6.16.2 Endo International Medical Transdermal Patch Description and Business Overview
  • 6.16.3 Endo International Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.16.4 Endo International Medical Transdermal Patch Product Portfolio
  • 6.16.5 Endo International Recent Developments/Updates
• 6.17 Beijing Tide Pharmaceutical
  • 6.17.1 Beijing Tide Pharmaceutical Corporation Information
  • 6.17.2 Beijing Tide Pharmaceutical Medical Transdermal Patch Description and Business Overview
  • 6.17.3 Beijing Tide Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
  • 6.17.4 Beijing Tide Pharmaceutical Medical Transdermal Patch Product Portfolio
  • 6.17.5 Beijing Tide Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

• 7.1 Medical Transdermal Patch Industry Chain Analysis
• 7.2 Medical Transdermal Patch Key Raw Materials
  • 7.2.1 Key Raw Materials
  • 7.2.2 Raw Materials Key Suppliers
• 7.3 Medical Transdermal Patch Production Mode & Process
• 7.4 Medical Transdermal Patch Sales and Marketing
  • 7.4.1 Medical Transdermal Patch Sales Channels
  • 7.4.2 Medical Transdermal Patch Distributors
• 7.5 Medical Transdermal Patch Customers

8 Medical Transdermal Patch Market Dynamics

• 8.1 Medical Transdermal Patch Industry Trends
• 8.2 Medical Transdermal Patch Market Drivers
• 8.3 Medical Transdermal Patch Market Challenges
• 8.4 Medical Transdermal Patch Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

• 10.1 Methodology/Research Approach
  • 10.1.1 Research Programs/Design
  • 10.1.2 Market Size Estimation
  • 10.1.3 Market Breakdown and Data Triangulation
• 10.2 Data Source
  • 10.2.1 Secondary Sources
  • 10.2.2 Primary Sources
• 10.3 Author List
• 10.4 Disclaimer

List of Tables

• Table 1. Global Medical Transdermal Patch Market Value Comparison by Type (2023-2029) & (US$ Million)
• Table 2. Global Medical Transdermal Patch Market Value Comparison by Application (2023-2029) & (US$ Million)
• Table 3. Global Medical Transdermal Patch Market Competitive Situation by Manufacturers in 2022
• Table 4. Global Medical Transdermal Patch Sales (K Units) of Key Manufacturers (2018-2023)
• Table 5. Global Medical Transdermal Patch Sales Market Share by Manufacturers (2018-2023)
• Table 6. Global Medical Transdermal Patch Revenue (US$ Million) by Manufacturers (2018-2023)
• Table 7. Global Medical Transdermal Patch Revenue Share by Manufacturers (2018-2023)
• Table 8. Global Market Medical Transdermal Patch Average Price (US$/Unit) of Key Manufacturers (2018-2023)
• Table 9. Global Key Players of Medical Transdermal Patch, Industry Ranking, 2021 VS 2022 VS 2023
• Table 10. Global Key Manufacturers of Medical Transdermal Patch, Manufacturing Sites & Headquarters
• Table 11. Global Key Manufacturers of Medical Transdermal Patch, Product Type & Application
• Table 12. Global Key Manufacturers of Medical Transdermal Patch, Date of Enter into This Industry
• Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 14. Global Medical Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Transdermal Patch as of 2022)
• Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
• Table 16. Global Medical Transdermal Patch Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
• Table 17. Global Medical Transdermal Patch Sales by Region (2018-2023) & (K Units)
• Table 18. Global Medical Transdermal Patch Sales Market Share by Region (2018-2023)
• Table 19. Global Medical Transdermal Patch Sales by Region (2024-2029) & (K Units)
• Table 20. Global Medical Transdermal Patch Sales Market Share by Region (2024-2029)
• Table 21. Global Medical Transdermal Patch Revenue by Region (2018-2023) & (US$ Million)
• Table 22. Global Medical Transdermal Patch Revenue Market Share by Region (2018-2023)
• Table 23. Global Medical Transdermal Patch Revenue by Region (2024-2029) & (US$ Million)
• Table 24. Global Medical Transdermal Patch Revenue Market Share by Region (2024-2029)
• Table 25. North America Medical Transdermal Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 26. North America Medical Transdermal Patch Sales by Country (2018-2023) & (K Units)
• Table 27. North America Medical Transdermal Patch Sales by Country (2024-2029) & (K Units)
• Table 28. North America Medical Transdermal Patch Revenue by Country (2018-2023) & (US$ Million)
• Table 29. North America Medical Transdermal Patch Revenue by Country (2024-2029) & (US$ Million)
• Table 30. Europe Medical Transdermal Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 31. Europe Medical Transdermal Patch Sales by Country (2018-2023) & (K Units)
• Table 32. Europe Medical Transdermal Patch Sales by Country (2024-2029) & (K Units)
• Table 33. Europe Medical Transdermal Patch Revenue by Country (2018-2023) & (US$ Million)
• Table 34. Europe Medical Transdermal Patch Revenue by Country (2024-2029) & (US$ Million)
• Table 35. Asia Pacific Medical Transdermal Patch Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 36. Asia Pacific Medical Transdermal Patch Sales by Region (2018-2023) & (K Units)
• Table 37. Asia Pacific Medical Transdermal Patch Sales by Region (2024-2029) & (K Units)
• Table 38. Asia Pacific Medical Transdermal Patch Revenue by Region (2018-2023) & (US$ Million)
• Table 39. Asia Pacific Medical Transdermal Patch Revenue by Region (2024-2029) & (US$ Million)
• Table 40. Latin America Medical Transdermal Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 41. Latin America Medical Transdermal Patch Sales by Country (2018-2023) & (K Units)
• Table 42. Latin America Medical Transdermal Patch Sales by Country (2024-2029) & (K Units)
• Table 43. Latin America Medical Transdermal Patch Revenue by Country (2018-2023) & (US$ Million)
• Table 44. Latin America Medical Transdermal Patch Revenue by Country (2024-2029) & (US$ Million)
• Table 45. Middle East & Africa Medical Transdermal Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 46. Middle East & Africa Medical Transdermal Patch Sales by Country (2018-2023) & (K Units)
• Table 47. Middle East & Africa Medical Transdermal Patch Sales by Country (2024-2029) & (K Units)
• Table 48. Middle East & Africa Medical Transdermal Patch Revenue by Country (2018-2023) & (US$ Million)
• Table 49. Middle East & Africa Medical Transdermal Patch Revenue by Country (2024-2029) & (US$ Million)
• Table 50. Global Medical Transdermal Patch Sales (K Units) by Type (2018-2023)
• Table 51. Global Medical Transdermal Patch Sales (K Units) by Type (2024-2029)
• Table 52. Global Medical Transdermal Patch Sales Market Share by Type (2018-2023)
• Table 53. Global Medical Transdermal Patch Sales Market Share by Type (2024-2029)
• Table 54. Global Medical Transdermal Patch Revenue (US$ Million) by Type (2018-2023)
• Table 55. Global Medical Transdermal Patch Revenue (US$ Million) by Type (2024-2029)
• Table 56. Global Medical Transdermal Patch Revenue Market Share by Type (2018-2023)
• Table 57. Global Medical Transdermal Patch Revenue Market Share by Type (2024-2029)
• Table 58. Global Medical Transdermal Patch Price (US$/Unit) by Type (2018-2023)
• Table 59. Global Medical Transdermal Patch Price (US$/Unit) by Type (2024-2029)
• Table 60. Global Medical Transdermal Patch Sales (K Units) by Application (2018-2023)
• Table 61. Global Medical Transdermal Patch Sales (K Units) by Application (2024-2029)
• Table 62. Global Medical Transdermal Patch Sales Market Share by Application (2018-2023)
• Table 63. Global Medical Transdermal Patch Sales Market Share by Application (2024-2029)
• Table 64. Global Medical Transdermal Patch Revenue (US$ Million) by Application (2018-2023)
• Table 65. Global Medical Transdermal Patch Revenue (US$ Million) by Application (2024-2029)
• Table 66. Global Medical Transdermal Patch Revenue Market Share by Application (2018-2023)
• Table 67. Global Medical Transdermal Patch Revenue Market Share by Application (2024-2029)
• Table 68. Global Medical Transdermal Patch Price (US$/Unit) by Application (2018-2023)
• Table 69. Global Medical Transdermal Patch Price (US$/Unit) by Application (2024-2029)
• Table 70. Hisamitsu Pharmaceutical Corporation Information
• Table 71. Hisamitsu Pharmaceutical Description and Business Overview
• Table 72. Hisamitsu Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 73. Hisamitsu Pharmaceutical Medical Transdermal Patch Product
• Table 74. Hisamitsu Pharmaceutical Recent Developments/Updates
• Table 75. Johnson & Johnson Corporation Information
• Table 76. Johnson & Johnson Description and Business Overview
• Table 77. Johnson & Johnson Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 78. Johnson & Johnson Medical Transdermal Patch Product
• Table 79. Johnson & Johnson Recent Developments/Updates
• Table 80. Novartis Corporation Information
• Table 81. Novartis Description and Business Overview
• Table 82. Novartis Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 83. Novartis Medical Transdermal Patch Product
• Table 84. Novartis Recent Developments/Updates
• Table 85. UCB Pharma Corporation Information
• Table 86. UCB Pharma Description and Business Overview
• Table 87. UCB Pharma Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 88. UCB Pharma Medical Transdermal Patch Product
• Table 89. UCB Pharma Recent Developments/Updates
• Table 90. Mylan Corporation Information
• Table 91. Mylan Description and Business Overview
• Table 92. Mylan Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 93. Mylan Medical Transdermal Patch Product
• Table 94. Mylan Recent Developments/Updates
• Table 95. Teva Pharmaceutical Corporation Information
• Table 96. Teva Pharmaceutical Description and Business Overview
• Table 97. Teva Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 98. Teva Pharmaceutical Medical Transdermal Patch Product
• Table 99. Teva Pharmaceutical Recent Developments/Updates
• Table 100. Nitto Denko Corporation Information
• Table 101. Nitto Denko Description and Business Overview
• Table 102. Nitto Denko Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 103. Nitto Denko Medical Transdermal Patch Product
• Table 104. Nitto Denko Recent Developments/Updates
• Table 105. Grunenthal Corporation Information
• Table 106. Grunenthal Description and Business Overview
• Table 107. Grunenthal Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 108. Grunenthal Medical Transdermal Patch Product
• Table 109. Grunenthal Recent Developments/Updates
• Table 110. IBSA Group Corporation Information
• Table 111. IBSA Group Description and Business Overview
• Table 112. IBSA Group Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 113. IBSA Group Medical Transdermal Patch Product
• Table 114. IBSA Group Recent Developments/Updates
• Table 115. GSK Corporation Information
• Table 116. GSK Description and Business Overview
• Table 117. GSK Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 118. GSK Medical Transdermal Patch Product
• Table 119. GSK Recent Developments/Updates
• Table 120. Luye Pharma Group Corporation Information
• Table 121. Luye Pharma Group Description and Business Overview
• Table 122. Luye Pharma Group Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 123. Luye Pharma Group Medical Transdermal Patch Product
• Table 124. Luye Pharma Group Recent Developments/Updates
• Table 125. Pfizer Corporation Information
• Table 126. Pfizer Description and Business Overview
• Table 127. Pfizer Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 128. Pfizer Medical Transdermal Patch Product
• Table 129. Pfizer Recent Developments/Updates
• Table 130. Chattem Corporation Information
• Table 131. Chattem Description and Business Overview
• Table 132. Chattem Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 133. Chattem Medical Transdermal Patch Product
• Table 134. Chattem Recent Developments/Updates
• Table 135. Bayer Corporation Information
• Table 136. Bayer Description and Business Overview
• Table 137. Bayer Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 138. Bayer Medical Transdermal Patch Product
• Table 139. Bayer Recent Developments/Updates
• Table 140. Mundipharma Corporation Information
• Table 141. Mundipharma Description and Business Overview
• Table 142. Mundipharma Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 143. Mundipharma Medical Transdermal Patch Product
• Table 144. Mundipharma Recent Developments/Updates
• Table 145. Endo International Corporation Information
• Table 146. Endo International Description and Business Overview
• Table 147. Endo International Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 148. Endo International Medical Transdermal Patch Product
• Table 149. Endo International Recent Developments/Updates
• Table 150. Beijing Tide Pharmaceutical Corporation Information
• Table 151. Beijing Tide Pharmaceutical Description and Business Overview
• Table 152. Beijing Tide Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 153. Beijing Tide Pharmaceutical Medical Transdermal Patch Product
• Table 154. Beijing Tide Pharmaceutical Recent Developments/Updates
• Table 155. Key Raw Materials Lists
• Table 156. Raw Materials Key Suppliers Lists
• Table 157. Medical Transdermal Patch Distributors List
• Table 158. Medical Transdermal Patch Customers List
• Table 159. Medical Transdermal Patch Market Trends
• Table 160. Medical Transdermal Patch Market Drivers
• Table 161. Medical Transdermal Patch Market Challenges
• Table 162. Medical Transdermal Patch Market Restraints
• Table 163. Research Programs/Design for This Report
• Table 164. Key Data Information from Secondary Sources
• Table 165. Key Data Information from Primary Sources

List of Figures

• Figure 1. Product Picture of Medical Transdermal Patch
• Figure 2. Global Medical Transdermal Patch Market Value Comparison by Type (2023-2029) & (US$ Million)
• Figure 3. Global Medical Transdermal Patch Market Share by Type in 2022 & 2029
• Figure 4. Methyl Salicylate-based Patch Product Picture
• Figure 5. Diclofenac Patch Product Picture
• Figure 6. Nicotine Transdermal Patch Product Picture
• Figure 7. Others Product Picture
• Figure 8. Global Medical Transdermal Patch Market Value Comparison by Application (2023-2029) & (US$ Million)
• Figure 9. Global Medical Transdermal Patch Market Share by Application in 2022 & 2029
• Figure 10. Rx Channel
• Figure 11. OTC Channel
• Figure 12. Global Medical Transdermal Patch Revenue, (US$ Million), 2018 VS 2022 VS 2029
• Figure 13. Global Medical Transdermal Patch Market Size (2018-2029) & (US$ Million)
• Figure 14. Global Medical Transdermal Patch Sales (2018-2029) & (K Units)
• Figure 15. Global Medical Transdermal Patch Average Price (US$/Unit) & (2018-2029)
• Figure 16. Medical Transdermal Patch Report Years Considered
• Figure 17. Medical Transdermal Patch Sales Share by Manufacturers in 2022
• Figure 18. Global Medical Transdermal Patch Revenue Share by Manufacturers in 2022
• Figure 19. The Global 5 and 10 Largest Medical Transdermal Patch Players: Market Share by Revenue in 2022
• Figure 20. Medical Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
• Figure 21. Global Medical Transdermal Patch Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
• Figure 22. North America Medical Transdermal Patch Sales Market Share by Country (2018-2029)
• Figure 23. North America Medical Transdermal Patch Revenue Market Share by Country (2018-2029)
• Figure 24. United States Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 25. Canada Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 26. Europe Medical Transdermal Patch Sales Market Share by Country (2018-2029)
• Figure 27. Europe Medical Transdermal Patch Revenue Market Share by Country (2018-2029)
• Figure 28. Germany Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 29. France Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 30. U.K. Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 31. Italy Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 32. Russia Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 33. Asia Pacific Medical Transdermal Patch Sales Market Share by Region (2018-2029)
• Figure 34. Asia Pacific Medical Transdermal Patch Revenue Market Share by Region (2018-2029)
• Figure 35. China Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 36. Japan Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 37. South Korea Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 38. India Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 39. Australia Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 40. China Taiwan Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 41. Indonesia Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 42. Thailand Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 43. Malaysia Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 44. Latin America Medical Transdermal Patch Sales Market Share by Country (2018-2029)
• Figure 45. Latin America Medical Transdermal Patch Revenue Market Share by Country (2018-2029)
• Figure 46. Mexico Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 47. Brazil Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 48. Argentina Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 49. Middle East & Africa Medical Transdermal Patch Sales Market Share by Country (2018-2029)
• Figure 50. Middle East & Africa Medical Transdermal Patch Revenue Market Share by Country (2018-2029)
• Figure 51. Turkey Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 52. Saudi Arabia Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 53. UAE Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
• Figure 54. Global Sales Market Share of Medical Transdermal Patch by Type (2018-2029)
• Figure 55. Global Revenue Market Share of Medical Transdermal Patch by Type (2018-2029)
• Figure 56. Global Medical Transdermal Patch Price (US$/Unit) by Type (2018-2029)
• Figure 57. Global Sales Market Share of Medical Transdermal Patch by Application (2018-2029)
• Figure 58. Global Revenue Market Share of Medical Transdermal Patch by Application (2018-2029)
• Figure 59. Global Medical Transdermal Patch Price (US$/Unit) by Application (2018-2029)
• Figure 60. Medical Transdermal Patch Value Chain
• Figure 61. Medical Transdermal Patch Production Process
• Figure 62. Channels of Distribution (Direct Vs Distribution)
• Figure 63. Distributors Profiles
• Figure 64. Bottom-up and Top-down Approaches for This Report
• Figure 65. Data Triangulation
• Figure 66. Key Executives Interviewed